Abstract:Objective To evaluate the predictive values of different systems for clinical staging of esophageal carcinoma in one group of patients and improve the criteria for T staging,and to provide a basis for accurate clinical staging. Methods A retrospective study was performed in 701 patients with esophageal carcinoma who received radical radiotherapy in our hospital. The prognosis was performed according to American Joint Committee on Cancer (AJCC) tumor-node-metastasis staging system,Chinese 2004 staging system,the draft of Chinese 2009 staging system,and gross tumor volume of the primary tumor (GTV-T). Results In terms of T stage,patients evaluated according to the AJCC staging system were in relatively early stages;23.1% of them were in stage T1,and the survival curves of T3 and T4 patients were close to each other;the survival curves plotted according to the Chinese 2004 staging system were well separated,but relatively few patients were in stages T1 and T4,yielding an uneven distribution;according to the draft of Chinese 2009 staging system,the survival curve of T3 patients intersected that of T4 patients,and up to 43.2% of patients were in stage T4.The new T staging was performed based on GTV and the extent of tumor invasion into the adjacent tissue and organ,and the results showed that there was no intersection between survival curves and a relatively balanced T stage distribution. In terms of N staging,patients were divided into stages N0,N1,and N2.The TNM staging was performed by a combination of N staging and new T staging,resulting in significant separation between survival curves (P=0.000). Conclusions The combination of T staging,which is based on GTV and the extent of tumor invasion,and N staging,which is based on metastasis of lymph nodes,can accurately predict the survival of non-surgically treated patients with esophageal carcinoma.
Zhu Shuchai,Yao Weinan,Li Juan et al. A comparative study of new clinical staging systems for esophageal carcinoma treated with non-surgical therapy[J]. Chinese Journal of Radiation Oncology, 2016, 25(2): 109-113.
[1]Wittekind C,Sobin LH.TNM classification of malignant tumours. New York (N.Y.):Wiley,2002. [2]祝淑钗,李任,李娟等.非手术治疗胸段食管癌临床分期与预后关系的初步探讨[J].中华放射肿瘤学杂志,2004,13(3):189-192.DOI:10.3760/j.issn:1004-4221.2004.03.010. Zhu SC,Li R,Li J,et al.Preliminary study of clinical staging of moderately advanced and advanced thoracic esophageal carcinoma treated by non-surgical methods[J].Chin J Radit Oncol,2004,13(3):189-192.DOI:10.3760/j.issn:1004-4221.2004.03.010. [3]中国非手术治疗食管癌临床分期专家小组.非手术治疗食管癌的临床分期标准(草案)[J].中华放射肿瘤学杂志,2010,19(3):179-180.DOI:10.3760/cma.j.issn.1004-4221.2010.03.001.The China Group of Experts on Non-surgical Clinical Staging for Esophageal Carcinoma,The Clinical Classification of Esophageal Carcinoma Treated by Non-surgical Methods[J].Chin J Radit Oncol,2010,19(3):179-180.DOI:10.3760/cma.j.issn.1004-4221.2010.03.001. [4]许茜,祝淑钗,刘志坤,等.食管癌大体肿瘤靶区的体积分级与病理T分期的关系[J].中华肿瘤杂志,2010,32(6):432-435.DOI:10.3760/cma.j.issn.0253-3766.2010.06.008. Xu Q,Zhu SC,Liu ZK,et al. Exploration of the classification of gross tumor volume and pathological staging of esophageal carcinoma[J].Chin J Oncol,2010,32(6):432-435.DOI:10.3760/cma.j.issn.0253-3766.2010.06.008. [5]陈龙奇.食管癌国际TNM分期第7版解读与评价[J].中华肿瘤杂志,2010,32(3):237-240.DOI:10.3760/cma.j.issn.0253-3766.2010.03.018. Chen LQ,Understanding and appraisal of the new TNM classification for esophageal cancer in the AJCC Cancer Staging Manual (7th ed)[J].Chin J Oncol,2010,32(3):237-240.DOI:10.3760/cma.j.issn.0253-3766.2010.03.018. [6]Hou X,Wei JC,Xu Y,et al.Proposed Modification of nodal categories in the seventh American joint committee of cancer staging system for esophageal squamous cell carcinoma in Chinese patients[J].Ann Thorac Surg,2014,21(1):337-342.DOI:10.1245/s10434-013-3265-2. [7]Reeh M,Nentwich MF,von Loga K,et alAn attempt at validation of the seventh edition of the classification by the international union against cancer for esophageal carcinoma[J].Ann Thorac Surg,2012,93(3):890-896.DOI:10.1016/j.athoracsur.2011.11.035. [8]谭立君,刘江涛,肖泽芬.食管癌UICC TNM分期的发展及临床应用[J].中华放射肿瘤学杂志,2014,23(4):365-368.DOI:10.3760/cma.j.issn.1004-4221.2014.04.024. Tan LJ,Liu JT,Xiao ZF,et al.The Application and Development of UICC TNM Staging on Esophageal Carcinoma[J].Chin J Radit Oncol,2014,23(4):365-368.DOI:10.3760/cma.j.issn.1004-4221.2014.04.024. [9]王澜,孔洁,韩春,等.非手术治疗食管癌临床分期标准的临床应用与探讨[J].中华放射肿瘤学杂志,2012,21(4):330-334.DOI:10.3760/cma.j.issn.1004-4221.2012.04.012. Wang L,Kong J,Han CH,et al. The evaluation of prognosis and investigation of clinical staging for esophageal carcinoma treated with non-surgical methods,[J].Chin J Radit Oncol,2012,21(4):330-334.DOI:10.3760/cma.j.issn.1004-4221.2012.04.012. [10]沈文斌,祝淑钗,李娟,等.食管癌临床分期对三维适形放射治疗预后的影响[J].中华放射医学与防护杂志,2008,28(4):371-374.DOI:10.3760/cma.j.issn.0254-5098.2008.04.016. Shen WB,Zhu SC,Li J,et al.Prognostic effect of clinical staging for esophageal carcinoma patients with three-dimensional conformal radiotherapy[J].Chin J Radiol Med Protect,2008,28(4):371-374.DOI:10.3760/cma.j.issn.0254-5098.2008.04.016. [11]王玉祥,祝淑钗,邱嵘,等.临床分期对食管鳞癌三维适型放疗后的指导价值[J].中华放射肿瘤学杂志,2011,20(2):113-117.DOI:10.3760/cma.j.issn.1004-4221.2011.02.009. Wang YX,Zhu SC,Qiu R,et al.Evaluation on prognosis of esophageal squamous cell carcinoma patients after three-dimensional conformal radiotherapy with different clinical stage system[J]. Chin J Radit Oncol,2011,20(2):113-117.DOI:10.3760/cma.j.issn.1004-4221.2011.02.009. [12]李娟,祝淑钗,刘志坤,等.食管癌3DCRTGTV-T体积与临床分期及预后的相关性分析[J].肿瘤防治研究,2015,42(7):693-696.DOI:10.3971/j.issn.1000-8578.2015.07.011. Li J,Zhu SC,Liu ZK,et al. Correlation between GTV-T Volume,clinical stage and prognosis of esophageal carcinoma patients treated with three-dimensional conformal radiotherapy[J].Cancer Res Prev Treat,2015,42(7):693-696. [13]李晓宁,王澜,韩春,等.食管癌 CT 图像 GTV 与三维放疗预后关系分析[J].中华放射肿瘤学杂志,2014,23(1):23-26.DOI:10.3760/cma.j.issn.1004-4221.2014.01.006. Li XN,Wang L,Han C,et al. Analysis of relationship between CT-GTV and prognosis in patients with esophageal cancer after three-dimensional radiotherapy[J].Chin J Radiat Oncol,2014,23(1):23-26.DOI:10.3760/cma.j.issn.1004-4221.2014.01.006.